Soluble Fas and soluble Fas ligand proteins in human milk: Possible significance in the development of immunological tolerance

被引:0
|
作者
Srivastava, MD [1 ]
Srivastava, BIS [1 ]
机构
[1] New York State Dept Hlth, Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human milk contains a complex uncharacterized, immune system able to exert actions both locally and systemically. This study reports the results of an ELISA-based quantitation of soluble Pas and soluble Fas ligand in human milk which may modulate the Fas/FasL system that is critical for the expression of immune tolerance and apoptosis. Production of Fas/FasL mRNAs by milk cells was also examined using RT-PCR. Pas is ubiquitously expressed in various cells and when bound by its ligand Fast, present predominantly on activated T- and NK cells, Fas-expressing cells are killed. A large amount of soluble Fas (1746-4320 pg/ml) is detected in colostrum, transitional milli and the mature milk of mothers delivering prematurely or at full-term, whereas Fast is present only in the range 123-310 pg/ml. Milk cells are positive for Fas mRNA, but negative for Fast mRNA. An excess of soluble Fas in human milk may bind to Fast preventing apoptosis and preserving epithelial barriers, and may represent an additional new mechanism whereby human milk favours immune tolerance and normal gastrointestinal development.
引用
收藏
页码:51 / 54
页数:4
相关论文
共 50 条
  • [1] Soluble FAS (S FAS) and soluble FAS ligand (S FAS-L) in human milk.
    Srivastava, MD
    FASEB JOURNAL, 1998, 12 (05): : A797 - A797
  • [2] Significance of Fas/Fas ligand and soluble Fas/Fas ligand system in patients with bile duct carcinoma
    Murakami, M
    Sasaki, T
    Tsuchida, A
    Kawasaki, Y
    Morinaka, K
    Fujimoto, Y
    Kariya, K
    Kuwada, Y
    Yamasaki, S
    Kuwahara, K
    Miyata, H
    Tyayama, K
    GASTROENTEROLOGY, 2002, 122 (04) : A442 - A442
  • [3] Prognostic Significance of Soluble Fas and Soluble Fas Ligand in Serum of Patients with Complete Hydatidiform Moles
    Soni, Simmi
    Rath, Gayatri
    Deval, Ravi
    Salhan, Sudha
    Mishra, Ashwini Kumar
    Saxena, Sunita
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (03) : 230 - 236
  • [4] SERUM SOLUBLE FAS AND SOLUBLE FAS LIGAND IN HYPERTENSION IN PREGNANCY
    Karthikeyan, Vellore J.
    Jessani, Shahirose
    Balakrishnan, Balu
    Lane, Deirdre A.
    Baghdadi, Sabah
    Beevers, D. Gareth
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [5] Plasma soluble Fas and soluble Fas ligand in chronic glomerulonephritis
    Sano, H
    Asano, K
    Minatoguchi, S
    Hiraoka, J
    Fujisawa, K
    Nishigaki, K
    Yasuda, N
    Kumada, H
    Takemura, M
    Ohashi, H
    Seishima, M
    Fujiwara, T
    Fujiwara, H
    NEPHRON, 1998, 80 (02) : 153 - 161
  • [6] Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer
    Mizutani, Y
    Yoshida, O
    Ukimura, O
    Kawauchi, A
    Bonavida, B
    Miki, T
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (05) : 563 - 567
  • [7] Associations Between Urine Soluble Fas and Soluble Fas Ligand Concentrations and Development of AKI in Sepsis
    Berg, R.
    Bhatraju, P.
    Harju-Baker, S.
    Mikacenic, C.
    Wurfel, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis
    Sugita, S
    Taguchi, C
    Takase, H
    Sagawa, K
    Sueda, J
    Fukushi, K
    Hikita, N
    Watanabe, T
    Itoh, K
    Mochizuki, M
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (10) : 1130 - 1134
  • [9] Soluble Fas Antigen and Soluble Fas Ligand in Intrauterine Growth Restriction
    Briana, Despina D.
    Baka, Stavroula
    Boutsikou, Maria
    Liosi, Sofia
    Vraila, Venetia-Maria
    Gourgiotis, Dimitrios
    Hassiakos, Dimitrios
    Malamitsi-Puchner, Ariadne
    NEONATOLOGY, 2010, 97 (01) : 31 - 35
  • [10] Soluble Fas antigen and soluble Fas ligand in early neonatal life
    Sarandakou, A
    Protonotariou, E
    Rizos, D
    Soubassi, L
    Malamitsi-Puchner, A
    EARLY HUMAN DEVELOPMENT, 2003, 75 (1-2) : 1 - 7